Intervention group (n = 14) | Control group (n = 7) | Difference between groups (95% CI) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baseline | 3 months | 6 months | 12 months | Baseline | 3 months | 6 months | 12 months | Baseline–6 months | |||||
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Difference (95% CI) | |
Whole-grain rye intake as reported in FFQ (g/day) | 61 (24) | N/A | 91a (33) | 182b (42) | 87a,d (32) | 200b,d (130) | 57 (26) | N/A | 56a (23) | 90b (20) | 54a,e (19) | 128b,e (49) | |
Compliance markers of whole-grain intake | |||||||||||||
Total plasma alkylresorcinols (nmol/L) | 109 (98) | 197 (87) | 211 (144) | 139d (76) | 74 (39) | 108 (66) | 102 (74) | 109 (55) | 93 (-30;215) | ||||
C17:C21 plasma alkylresorcinols ratio | 0.39 (0.19) | 0.43 (0.17) | 0.42 (0.20) | 0.49d (0.21) | 0.30 (0.10) | 0.32 (0.10) | 0.29 (0.05) | 0.58 (0.25) | 0.08 (-0.07;0.22) | ||||
Intervention group (n = 14 for whole-grain intake and n = 12 for physical activity measures) | Control group No assessment of whole-grain intake from diaries or physical activity done for the control group | ||||||||||||
Baseline–3 months | 3–6 months | 12 months | |||||||||||
Mean (SD) | Mean (SD) | ||||||||||||
Whole-grain rye intake as reported in diary (g/day) | 146 (19) | 125 (40) | N/A | ||||||||||
Median (P5;P95) | Median (P5;P95) | ||||||||||||
Physical activity (min/week) | |||||||||||||
Above 70% of max - based on heart rate monitor | 91 (17, 193) | 66 (13, 259) | N/A | ||||||||||
Total - based on heart rate monitor | 220 (31, 338) | 150 (66, 319) | N/A | ||||||||||
Total - based on heart rate monitor + diary | 285 (58, 452) | 225 (77, 355) | N/A |